Skip to main content

Methyldopa Tablets Shortage

Last Updated: November 17, 2023
Status: Resolved

Products Affected - Description
    • Methyldopa oral tablet, Accord, 250 mg, bottle, 100 count, NDC 16729-0030-01 - discontinued
    • Methyldopa oral tablet, Accord, 250 mg, bottle, 500 count, NDC 16729-0030-16 - discontinued
    • Methyldopa oral tablet, Accord, 500 mg, bottle, 100 count, NDC 16729-0031-01 - discontinued
    • Methyldopa oral tablet, Accord, 500 mg, bottle, 500 count, NDC 16729-0031-16 - discontinued
    • Methyldopa oral tablet, Mylan (Viatris), 250 mg, bottle, 100 count, NDC 00378-0611-01 - discontinued
    • Methyldopa oral tablet, Mylan (Viatris), 500 mg, bottle, 100 count, NDC 00378-0421-01 - discontinued
Reason for the Shortage
    • Accord discontinued methyldopa tablets.
    • Chartwell launched methyldopa tablets in November 2023.
    • Mylan discontinued methyldopa in June 2021.
Available Products
    • Methyldopa oral tablet, Chartwell, 250 mg, bottle, 90 count, NDC 62135-0321-90
    • Methyldopa oral tablet, Chartwell, 250 mg, bottle, 180 count, NDC 62135-0321-18
    • Methyldopa oral tablet, Chartwell, 500 mg, bottle, 90 count, NDC 62135-0322-90
    • Methyldopa oral tablet, Chartwell, 500 mg, bottle, 180 count, NDC 62135-0322-18

Updated

Updated November 17, 2023 by Leslie Jensen, PharmD, Drug Information Specialist. Created November 10, 2023 by Leslie Jensen, PharmD, Drug Information Specialist. © 2023, Drug Information Service, University of Utah, Salt Lake City, UT.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer